Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Thor Medical

Ylin-
Alin-
Vaihto-
2026 H1 - tulosraportti
21 päivää sitten

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1--
1 023--
12 083--
3 504--
4 513--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 H2 - tulosraportti
26.2.2027
Menneet tapahtumat
2026 H1 - tulosraportti
28.8.
2025 H2 - tulosraportti
26.2.
2025 H1 - tulosraportti
29.8.2025
2024 H2 - tulosraportti
26.2.2025
2024 H1 - tulosraportti
30.8.2024

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 1 t sitten · Muokattu
    ·
    guynextdoor7 I honestly think that analysis is far too contrived. You start with a bearish Elliott Wave scenario and then build a lot of levels on top, which in practice can be drawn in several different ways. When you simultaneously don't own the stock and clearly want to buy lower, it's hard not to get the impression that the analysis also very conveniently fits your own desire for a lower price. Pointing to 2.80, 2.00 and all the way down towards 1.60 solely based on wave theory seems very speculative in a small, news-driven stock like Thor. A strong announcement about sales, deliveries or production can change the whole picture in one day. So I simply don't buy the premise that the stock "must" go significantly lower before it can rise again. It's one possible technical narrative — not a definitive answer.
    51 min sitten
    Thanks for the thoughtful criticism. I agree that Elliott Wave counts are subjective and that material company news can invalidate a technical setup immediately—especially in a small, news-driven stock. However, I did not say Thor Medical “must” fall to NOK 2.80, 2.00 or 1.60. These are conditional reaction zones, not inevitable price targets. The deeper levels only become relevant if successive supports fail, particularly the weekly structure around NOK 3.98–4.05. The analysis is also not based solely on Elliott Wave. It combines market structure, liquidity, order blocks, anchored volume profile, Fibonacci levels and momentum. At present, the daily structure is bearish, while the weekly structure remains bullish as long as NOK 3.98–4.05 holds. Therefore, a shallow correction and renewed advance remain entirely possible. A decisive move above NOK 7.03 would invalidate the current corrective count. Regarding ownership, confirmation bias is a valid concern whether someone owns the share or is waiting to enter. That is precisely why I try to show both bullish and bearish scenarios together with their confirmation and invalidation levels. So I agree with your final point: this is one possible technical map, not a definitive answer key. The purpose is to prepare for different outcomes—not to claim that the market has to follow one particular path.
  • 2 t sitten
    Thor Medical ASA (TRMED) – Elliott Wave and Multi-Timeframe Technical Analysis Thor Medical may have completed a major first wave at NOK 7.03, but the technical picture now points toward a corrective phase before the next sustainable advance. Because the listed company was previously Nordic Nanovector, I consider the NOK 0.639 low from 2023 the most relevant starting point for the present Thor Medical structure. Elliott Wave structure The advance from NOK 0.639 to NOK 7.03 can be counted as five waves. However, wave (4) overlaps wave (1), meaning it cannot be classified as a conventional impulse. The more appropriate interpretation is a possible leading diagonal forming major wave ①. The reversal from NOK 7.03 may therefore represent the beginning of major wave ②. Leading diagonals are frequently followed by relatively deep second-wave corrections. Market structure The daily and weekly charts currently show an important timeframe transition: * Daily swing trend: bearish * Daily internal trend: bearish * Last daily event: bearish Swing CHoCH * Weekly swing and internal trends: still bullish * Last weekly event: bullish BOS * Both timeframes registered a buy-side liquidity sweep before the reversal The daily structure has therefore confirmed a bearish shift, while the weekly structure has not yet officially turned bearish. The decisive weekly level is approximately NOK 3.98–4.05. A confirmed weekly close below this area would produce stronger evidence that major wave ② is underway. Anchored Volume Profile The profile is anchored from the 2023 low to the NOK 7.03 high and uses the current Thor Medical price structure: * VAH: approximately NOK 5.7–5.9 * POC: approximately NOK 4.55–4.65 * Secondary HVN: approximately NOK 2.6–2.83 * VAL: approximately NOK 1.85–1.95 The current price of NOK 4.605 is positioned almost exactly at the POC. This means the market is presently near its main accepted price and has not yet selected a clear longer-term direction. Acceptance below the POC, followed by a weekly break below NOK 3.98, would favour rotation toward the secondary HVN around NOK 2.6–2.83. Liquidity and volumetric order blocks The nearest important demand area is around NOK 3.70–4.05, where weekly liquidity, a Buy OB and the NOK 3.99 Fibonacci level converge. A deeper and potentially more important demand area is around NOK 1.47–1.70. This zone combines: * Weekly liquidity * Previous wave-(4) territory * The logarithmic 0.618 retracement at NOK 1.598 The first significant overhead Sell OB is around NOK 10–12. Additional supply is visible around NOK 18–22 and at higher historical levels. WaveTrend Momentum supports an early corrective phase: * Daily WaveTrend is bearish and below zero, although not deeply oversold. * Weekly WaveTrend is bearish, with the fast line below the signal line and a negative histogram. * Monthly WaveTrend remains marginally positive but has flattened near the upper region following a SELL warning. This suggests that the correction is confirmed on the lower timeframe, developing on the weekly timeframe and not yet fully confirmed on the monthly chart. Preferred corrective scenario My current preferred path is: 1. Weekly acceptance below NOK 3.98–4.05 2. Wave A toward NOK 2.45–2.83 3. Wave B rebound toward NOK 4.0–4.65, potentially NOK 5.36 4. Bearish continuation below the wave-A low 5. Wave C toward NOK 1.85–2.12 6. Possible final liquidity sweep toward NOK 1.598 NOK 1.598 should be viewed as a deeper sweep target rather than a guaranteed destination. For a confirmed wave-② bottom, I would want to see a liquidity sweep followed by a reclaim, bullish CHoCH and BOS, a confirmed Buy OB with volume expansion and bullish WaveTrend divergence. Bullish alternative If NOK 3.98–4.05 holds and price subsequently reclaims: * NOK 5.36 * VAH around NOK 5.7–5.9 * NOK 7.03 then the correction may remain considerably shallower. A sustained breakout above NOK 7.03 would require the Elliott count to be advanced or revised. Long-term outlook After a confirmed wave-② completion and a new breakout above NOK 7.03, the more defensible wave-③ objectives would initially be: * NOK 11–14 * Extended target around NOK 18–21 The much higher logarithmic projections around NOK 80 and NOK 200 remain highly speculative and should not be treated as active targets before the lower Sell OBs and resistance zones have been decisively absorbed. Conclusion The long-term potential remains bullish, but the shorter-term evidence currently favours correction: Daily structure is bearish, weekly momentum is bearish, but weekly price structure remains technically bullish until NOK 3.98–4.05 is broken. The market’s reaction around NOK 4.00 will likely determine whether Thor Medical forms a shallow correction or develops the larger ABC wave-② structure shown on the chart. This is my personal technical interpretation and not financial advice.
    1 t sitten
    ·
    I honestly think that analysis is far too contrived. You start with a bearish Elliott Wave scenario and then build a lot of levels on top, which in practice can be drawn in several different ways. When you also don't own the stock and clearly want to buy lower, it's hard not to get the impression that the analysis also conveniently fits your own desire for a lower price. Pointing to 2.80, 2.00 and all the way down to 1.60 solely based on wave theory seems very speculative in a small, news-driven stock like Thor. A strong announcement about sales, deliveries or production can change the entire picture in one day. So I simply don't buy the premise that the stock "must" go significantly lower before it can rise again. It's one possible technical narrative — not a definitive answer key.
  • 3 t sitten
    ·
    Thor Medical is gearing up for growth AlphaOne is in commercial operation, and the company will now scale production and operations. The hunt for a commercial CFO with capital market experience shows clear ambitions – with both growth and profitability in focus. No confirmation on AlphaTwo or a new share issue, but the next proof must be increased deliveries, revenues, and better cash flow. Source: Økonomi24, September 15, 2026.
  • 8 t sitten
    ·
    I thought about it when I looked at the chart and realized why 4.6 might be hit. 4.6 was hit a few days ago too, before it reacted upwards shortly after (yes, it went a little below). The peak at ~7.1 kroner looks like the left shoulder in an inverse head-and-shoulders formation. 4.6-4.8-4.6 again becomes the "head" and if it maintains itself the way I see it, then it could become a reality that it will go up towards 7kr to complete this. In addition, volume is mainly lower around bottoms and high around tops (excluding the emission shares at 4.8). This is a somewhat speculative theory, like everything else here in the stock market. It might still be worth thinking about, since investor psychology likes patterns.
    4 t sitten
    ·
    Is DNB right, Fesk? Then you are way over.
  • 10 t sitten
    ·
    Nice to pick up some shares at these levels.
    3 t sitten
    ·
    A lot to pick up? The stock has been below 5kr for 4 years 😂
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

Välittäjätilasto

Dataa ei löytynyt
2026 H1 - tulosraportti
21 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 1 t sitten · Muokattu
    ·
    guynextdoor7 I honestly think that analysis is far too contrived. You start with a bearish Elliott Wave scenario and then build a lot of levels on top, which in practice can be drawn in several different ways. When you simultaneously don't own the stock and clearly want to buy lower, it's hard not to get the impression that the analysis also very conveniently fits your own desire for a lower price. Pointing to 2.80, 2.00 and all the way down towards 1.60 solely based on wave theory seems very speculative in a small, news-driven stock like Thor. A strong announcement about sales, deliveries or production can change the whole picture in one day. So I simply don't buy the premise that the stock "must" go significantly lower before it can rise again. It's one possible technical narrative — not a definitive answer.
    51 min sitten
    Thanks for the thoughtful criticism. I agree that Elliott Wave counts are subjective and that material company news can invalidate a technical setup immediately—especially in a small, news-driven stock. However, I did not say Thor Medical “must” fall to NOK 2.80, 2.00 or 1.60. These are conditional reaction zones, not inevitable price targets. The deeper levels only become relevant if successive supports fail, particularly the weekly structure around NOK 3.98–4.05. The analysis is also not based solely on Elliott Wave. It combines market structure, liquidity, order blocks, anchored volume profile, Fibonacci levels and momentum. At present, the daily structure is bearish, while the weekly structure remains bullish as long as NOK 3.98–4.05 holds. Therefore, a shallow correction and renewed advance remain entirely possible. A decisive move above NOK 7.03 would invalidate the current corrective count. Regarding ownership, confirmation bias is a valid concern whether someone owns the share or is waiting to enter. That is precisely why I try to show both bullish and bearish scenarios together with their confirmation and invalidation levels. So I agree with your final point: this is one possible technical map, not a definitive answer key. The purpose is to prepare for different outcomes—not to claim that the market has to follow one particular path.
  • 2 t sitten
    Thor Medical ASA (TRMED) – Elliott Wave and Multi-Timeframe Technical Analysis Thor Medical may have completed a major first wave at NOK 7.03, but the technical picture now points toward a corrective phase before the next sustainable advance. Because the listed company was previously Nordic Nanovector, I consider the NOK 0.639 low from 2023 the most relevant starting point for the present Thor Medical structure. Elliott Wave structure The advance from NOK 0.639 to NOK 7.03 can be counted as five waves. However, wave (4) overlaps wave (1), meaning it cannot be classified as a conventional impulse. The more appropriate interpretation is a possible leading diagonal forming major wave ①. The reversal from NOK 7.03 may therefore represent the beginning of major wave ②. Leading diagonals are frequently followed by relatively deep second-wave corrections. Market structure The daily and weekly charts currently show an important timeframe transition: * Daily swing trend: bearish * Daily internal trend: bearish * Last daily event: bearish Swing CHoCH * Weekly swing and internal trends: still bullish * Last weekly event: bullish BOS * Both timeframes registered a buy-side liquidity sweep before the reversal The daily structure has therefore confirmed a bearish shift, while the weekly structure has not yet officially turned bearish. The decisive weekly level is approximately NOK 3.98–4.05. A confirmed weekly close below this area would produce stronger evidence that major wave ② is underway. Anchored Volume Profile The profile is anchored from the 2023 low to the NOK 7.03 high and uses the current Thor Medical price structure: * VAH: approximately NOK 5.7–5.9 * POC: approximately NOK 4.55–4.65 * Secondary HVN: approximately NOK 2.6–2.83 * VAL: approximately NOK 1.85–1.95 The current price of NOK 4.605 is positioned almost exactly at the POC. This means the market is presently near its main accepted price and has not yet selected a clear longer-term direction. Acceptance below the POC, followed by a weekly break below NOK 3.98, would favour rotation toward the secondary HVN around NOK 2.6–2.83. Liquidity and volumetric order blocks The nearest important demand area is around NOK 3.70–4.05, where weekly liquidity, a Buy OB and the NOK 3.99 Fibonacci level converge. A deeper and potentially more important demand area is around NOK 1.47–1.70. This zone combines: * Weekly liquidity * Previous wave-(4) territory * The logarithmic 0.618 retracement at NOK 1.598 The first significant overhead Sell OB is around NOK 10–12. Additional supply is visible around NOK 18–22 and at higher historical levels. WaveTrend Momentum supports an early corrective phase: * Daily WaveTrend is bearish and below zero, although not deeply oversold. * Weekly WaveTrend is bearish, with the fast line below the signal line and a negative histogram. * Monthly WaveTrend remains marginally positive but has flattened near the upper region following a SELL warning. This suggests that the correction is confirmed on the lower timeframe, developing on the weekly timeframe and not yet fully confirmed on the monthly chart. Preferred corrective scenario My current preferred path is: 1. Weekly acceptance below NOK 3.98–4.05 2. Wave A toward NOK 2.45–2.83 3. Wave B rebound toward NOK 4.0–4.65, potentially NOK 5.36 4. Bearish continuation below the wave-A low 5. Wave C toward NOK 1.85–2.12 6. Possible final liquidity sweep toward NOK 1.598 NOK 1.598 should be viewed as a deeper sweep target rather than a guaranteed destination. For a confirmed wave-② bottom, I would want to see a liquidity sweep followed by a reclaim, bullish CHoCH and BOS, a confirmed Buy OB with volume expansion and bullish WaveTrend divergence. Bullish alternative If NOK 3.98–4.05 holds and price subsequently reclaims: * NOK 5.36 * VAH around NOK 5.7–5.9 * NOK 7.03 then the correction may remain considerably shallower. A sustained breakout above NOK 7.03 would require the Elliott count to be advanced or revised. Long-term outlook After a confirmed wave-② completion and a new breakout above NOK 7.03, the more defensible wave-③ objectives would initially be: * NOK 11–14 * Extended target around NOK 18–21 The much higher logarithmic projections around NOK 80 and NOK 200 remain highly speculative and should not be treated as active targets before the lower Sell OBs and resistance zones have been decisively absorbed. Conclusion The long-term potential remains bullish, but the shorter-term evidence currently favours correction: Daily structure is bearish, weekly momentum is bearish, but weekly price structure remains technically bullish until NOK 3.98–4.05 is broken. The market’s reaction around NOK 4.00 will likely determine whether Thor Medical forms a shallow correction or develops the larger ABC wave-② structure shown on the chart. This is my personal technical interpretation and not financial advice.
    1 t sitten
    ·
    I honestly think that analysis is far too contrived. You start with a bearish Elliott Wave scenario and then build a lot of levels on top, which in practice can be drawn in several different ways. When you also don't own the stock and clearly want to buy lower, it's hard not to get the impression that the analysis also conveniently fits your own desire for a lower price. Pointing to 2.80, 2.00 and all the way down to 1.60 solely based on wave theory seems very speculative in a small, news-driven stock like Thor. A strong announcement about sales, deliveries or production can change the entire picture in one day. So I simply don't buy the premise that the stock "must" go significantly lower before it can rise again. It's one possible technical narrative — not a definitive answer key.
  • 3 t sitten
    ·
    Thor Medical is gearing up for growth AlphaOne is in commercial operation, and the company will now scale production and operations. The hunt for a commercial CFO with capital market experience shows clear ambitions – with both growth and profitability in focus. No confirmation on AlphaTwo or a new share issue, but the next proof must be increased deliveries, revenues, and better cash flow. Source: Økonomi24, September 15, 2026.
  • 8 t sitten
    ·
    I thought about it when I looked at the chart and realized why 4.6 might be hit. 4.6 was hit a few days ago too, before it reacted upwards shortly after (yes, it went a little below). The peak at ~7.1 kroner looks like the left shoulder in an inverse head-and-shoulders formation. 4.6-4.8-4.6 again becomes the "head" and if it maintains itself the way I see it, then it could become a reality that it will go up towards 7kr to complete this. In addition, volume is mainly lower around bottoms and high around tops (excluding the emission shares at 4.8). This is a somewhat speculative theory, like everything else here in the stock market. It might still be worth thinking about, since investor psychology likes patterns.
    4 t sitten
    ·
    Is DNB right, Fesk? Then you are way over.
  • 10 t sitten
    ·
    Nice to pick up some shares at these levels.
    3 t sitten
    ·
    A lot to pick up? The stock has been below 5kr for 4 years 😂
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1--
1 023--
12 083--
3 504--
4 513--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 H2 - tulosraportti
26.2.2027
Menneet tapahtumat
2026 H1 - tulosraportti
28.8.
2025 H2 - tulosraportti
26.2.
2025 H1 - tulosraportti
29.8.2025
2024 H2 - tulosraportti
26.2.2025
2024 H1 - tulosraportti
30.8.2024

Tuotteita joiden kohde-etuutena tämä arvopaperi

Välittäjätilasto

Dataa ei löytynyt
2026 H1 - tulosraportti
21 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: Quartr
Seuraava tapahtuma
2026 H2 - tulosraportti
26.2.2027
Menneet tapahtumat
2026 H1 - tulosraportti
28.8.
2025 H2 - tulosraportti
26.2.
2025 H1 - tulosraportti
29.8.2025
2024 H2 - tulosraportti
26.2.2025
2024 H1 - tulosraportti
30.8.2024

Tuotteita joiden kohde-etuutena tämä arvopaperi

Foorumi

Liity keskusteluun Nordnet Socialissa
Kirjaudu
  • 1 t sitten · Muokattu
    ·
    guynextdoor7 I honestly think that analysis is far too contrived. You start with a bearish Elliott Wave scenario and then build a lot of levels on top, which in practice can be drawn in several different ways. When you simultaneously don't own the stock and clearly want to buy lower, it's hard not to get the impression that the analysis also very conveniently fits your own desire for a lower price. Pointing to 2.80, 2.00 and all the way down towards 1.60 solely based on wave theory seems very speculative in a small, news-driven stock like Thor. A strong announcement about sales, deliveries or production can change the whole picture in one day. So I simply don't buy the premise that the stock "must" go significantly lower before it can rise again. It's one possible technical narrative — not a definitive answer.
    51 min sitten
    Thanks for the thoughtful criticism. I agree that Elliott Wave counts are subjective and that material company news can invalidate a technical setup immediately—especially in a small, news-driven stock. However, I did not say Thor Medical “must” fall to NOK 2.80, 2.00 or 1.60. These are conditional reaction zones, not inevitable price targets. The deeper levels only become relevant if successive supports fail, particularly the weekly structure around NOK 3.98–4.05. The analysis is also not based solely on Elliott Wave. It combines market structure, liquidity, order blocks, anchored volume profile, Fibonacci levels and momentum. At present, the daily structure is bearish, while the weekly structure remains bullish as long as NOK 3.98–4.05 holds. Therefore, a shallow correction and renewed advance remain entirely possible. A decisive move above NOK 7.03 would invalidate the current corrective count. Regarding ownership, confirmation bias is a valid concern whether someone owns the share or is waiting to enter. That is precisely why I try to show both bullish and bearish scenarios together with their confirmation and invalidation levels. So I agree with your final point: this is one possible technical map, not a definitive answer key. The purpose is to prepare for different outcomes—not to claim that the market has to follow one particular path.
  • 2 t sitten
    Thor Medical ASA (TRMED) – Elliott Wave and Multi-Timeframe Technical Analysis Thor Medical may have completed a major first wave at NOK 7.03, but the technical picture now points toward a corrective phase before the next sustainable advance. Because the listed company was previously Nordic Nanovector, I consider the NOK 0.639 low from 2023 the most relevant starting point for the present Thor Medical structure. Elliott Wave structure The advance from NOK 0.639 to NOK 7.03 can be counted as five waves. However, wave (4) overlaps wave (1), meaning it cannot be classified as a conventional impulse. The more appropriate interpretation is a possible leading diagonal forming major wave ①. The reversal from NOK 7.03 may therefore represent the beginning of major wave ②. Leading diagonals are frequently followed by relatively deep second-wave corrections. Market structure The daily and weekly charts currently show an important timeframe transition: * Daily swing trend: bearish * Daily internal trend: bearish * Last daily event: bearish Swing CHoCH * Weekly swing and internal trends: still bullish * Last weekly event: bullish BOS * Both timeframes registered a buy-side liquidity sweep before the reversal The daily structure has therefore confirmed a bearish shift, while the weekly structure has not yet officially turned bearish. The decisive weekly level is approximately NOK 3.98–4.05. A confirmed weekly close below this area would produce stronger evidence that major wave ② is underway. Anchored Volume Profile The profile is anchored from the 2023 low to the NOK 7.03 high and uses the current Thor Medical price structure: * VAH: approximately NOK 5.7–5.9 * POC: approximately NOK 4.55–4.65 * Secondary HVN: approximately NOK 2.6–2.83 * VAL: approximately NOK 1.85–1.95 The current price of NOK 4.605 is positioned almost exactly at the POC. This means the market is presently near its main accepted price and has not yet selected a clear longer-term direction. Acceptance below the POC, followed by a weekly break below NOK 3.98, would favour rotation toward the secondary HVN around NOK 2.6–2.83. Liquidity and volumetric order blocks The nearest important demand area is around NOK 3.70–4.05, where weekly liquidity, a Buy OB and the NOK 3.99 Fibonacci level converge. A deeper and potentially more important demand area is around NOK 1.47–1.70. This zone combines: * Weekly liquidity * Previous wave-(4) territory * The logarithmic 0.618 retracement at NOK 1.598 The first significant overhead Sell OB is around NOK 10–12. Additional supply is visible around NOK 18–22 and at higher historical levels. WaveTrend Momentum supports an early corrective phase: * Daily WaveTrend is bearish and below zero, although not deeply oversold. * Weekly WaveTrend is bearish, with the fast line below the signal line and a negative histogram. * Monthly WaveTrend remains marginally positive but has flattened near the upper region following a SELL warning. This suggests that the correction is confirmed on the lower timeframe, developing on the weekly timeframe and not yet fully confirmed on the monthly chart. Preferred corrective scenario My current preferred path is: 1. Weekly acceptance below NOK 3.98–4.05 2. Wave A toward NOK 2.45–2.83 3. Wave B rebound toward NOK 4.0–4.65, potentially NOK 5.36 4. Bearish continuation below the wave-A low 5. Wave C toward NOK 1.85–2.12 6. Possible final liquidity sweep toward NOK 1.598 NOK 1.598 should be viewed as a deeper sweep target rather than a guaranteed destination. For a confirmed wave-② bottom, I would want to see a liquidity sweep followed by a reclaim, bullish CHoCH and BOS, a confirmed Buy OB with volume expansion and bullish WaveTrend divergence. Bullish alternative If NOK 3.98–4.05 holds and price subsequently reclaims: * NOK 5.36 * VAH around NOK 5.7–5.9 * NOK 7.03 then the correction may remain considerably shallower. A sustained breakout above NOK 7.03 would require the Elliott count to be advanced or revised. Long-term outlook After a confirmed wave-② completion and a new breakout above NOK 7.03, the more defensible wave-③ objectives would initially be: * NOK 11–14 * Extended target around NOK 18–21 The much higher logarithmic projections around NOK 80 and NOK 200 remain highly speculative and should not be treated as active targets before the lower Sell OBs and resistance zones have been decisively absorbed. Conclusion The long-term potential remains bullish, but the shorter-term evidence currently favours correction: Daily structure is bearish, weekly momentum is bearish, but weekly price structure remains technically bullish until NOK 3.98–4.05 is broken. The market’s reaction around NOK 4.00 will likely determine whether Thor Medical forms a shallow correction or develops the larger ABC wave-② structure shown on the chart. This is my personal technical interpretation and not financial advice.
    1 t sitten
    ·
    I honestly think that analysis is far too contrived. You start with a bearish Elliott Wave scenario and then build a lot of levels on top, which in practice can be drawn in several different ways. When you also don't own the stock and clearly want to buy lower, it's hard not to get the impression that the analysis also conveniently fits your own desire for a lower price. Pointing to 2.80, 2.00 and all the way down to 1.60 solely based on wave theory seems very speculative in a small, news-driven stock like Thor. A strong announcement about sales, deliveries or production can change the entire picture in one day. So I simply don't buy the premise that the stock "must" go significantly lower before it can rise again. It's one possible technical narrative — not a definitive answer key.
  • 3 t sitten
    ·
    Thor Medical is gearing up for growth AlphaOne is in commercial operation, and the company will now scale production and operations. The hunt for a commercial CFO with capital market experience shows clear ambitions – with both growth and profitability in focus. No confirmation on AlphaTwo or a new share issue, but the next proof must be increased deliveries, revenues, and better cash flow. Source: Økonomi24, September 15, 2026.
  • 8 t sitten
    ·
    I thought about it when I looked at the chart and realized why 4.6 might be hit. 4.6 was hit a few days ago too, before it reacted upwards shortly after (yes, it went a little below). The peak at ~7.1 kroner looks like the left shoulder in an inverse head-and-shoulders formation. 4.6-4.8-4.6 again becomes the "head" and if it maintains itself the way I see it, then it could become a reality that it will go up towards 7kr to complete this. In addition, volume is mainly lower around bottoms and high around tops (excluding the emission shares at 4.8). This is a somewhat speculative theory, like everything else here in the stock market. It might still be worth thinking about, since investor psychology likes patterns.
    4 t sitten
    ·
    Is DNB right, Fesk? Then you are way over.
  • 10 t sitten
    ·
    Nice to pick up some shares at these levels.
    3 t sitten
    ·
    A lot to pick up? The stock has been below 5kr for 4 years 😂
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
1--
1 023--
12 083--
3 504--
4 513--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Rahastot ja ETF:t, joilla on osaketta

Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.

Välittäjätilasto

Dataa ei löytynyt